Mindray's 2022 employee stock plan faces partial unlock failure

Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) announced that the third batch of shares under its 2022 Employee Stock Ownership Plan will not be unlocked on May 25, 2025, as initially planned. According to the company's filing, the unlocking condition related to corporate performance targets was not met, resulting in the management committee reclaiming the shares. The original transfer of 3,048,662 shares, accounting for 0.25% of the company's total share capital, occurred on May 25, 2022, at a price of CNY 50.00 per share. Employees affected by the unfulfilled unlocking will receive either the original investment plus bank interest or the proceeds from the shares, whichever is lower. Mindray will continue to monitor the plan's implementation and adhere to disclosure requirements.